The audit of the companys formulations manufacturing plant (Vizag SEZ Plant 1) at Duvvada, Visakhapatnam by the USFDA, has been completed on Tuesday, and it has been issued a Form 483 with 8 observations, the company said in the filing.
from India Infoline News Service https://ift.tt/2MtyXhn
No comments:
Post a Comment